from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1620c/cydC

LFCtreatmentdescriptionclass of inhibitor

-0.951

Amikacinug/mL Amikacintranslation

-1.232

Cap5-10ug/mL Capreomycintranslation

-1.658

Rox10-50 ug/mL Roxithromycintranslation

-1.306

SM2-5 ug/mL Streptomycintranslation

-1.722

Tet5-10 ug/mL Tetracyclinetranslation

-0.575

Rif0.2-5ug/mL Rifampicintranscription

-0.231

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.275

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.059

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.638

CPZ10-50 ug/mL Chlorpromazinerespiration

2.342

Clofazimine10-13 ug/mL Clofaziminerespiration

1.311

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.745

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.078

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.029

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.847

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.757

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.403

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.984

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.331

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.887

KCN5-20 ug/mL Potassium cyaniderespiration

1.297

NaN30.2-2 mM Sodium aziderespiration

0.625

Nigericin50 uM Nigericinrespiration

0.473

TRC10-150 ug/mL Triclosanrespiration

0.614

TRZ10-25 ug/mL Thioridazinerespiration

-0.786

Valinomycin0.5-10 uM Valinomycinrespiration

-0.381

ZnSO42 mM ZnSO4respiration

-0.441

menadione6-10 ug/mL Menadionerespiration

0.900

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.618

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.583

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.125

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.075

NRP_1Non-replicating persistence stage 1dosRassociated

-0.510

Amp0.2mg/mL AmpicillincellWall

-0.298

Cephalexin20-100 ug/mL CephalexincellWall

-0.737

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.360

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.880

EMB10-20 ug/mL EthambutolcellWall

-0.122

Eta12-40 ug/mL EthionamidecellWall

-0.359

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.288

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.694

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.951

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.054

BZA0.12 mg/mL BenzamidearomaticAmides

-0.383

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.508

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.194

H2O24 mM hydrogen peroxideDNAdamaging

-0.402

Levo10 ug/mL LevofloxacinDNAdamaging

-0.712

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.767

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.742

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.910

UVUV-irradiationDNAdamaging

0.062

ARP41-4 ug/mL Antitubercular compound ARP4?

0.001

Antimycin12.5-50 ug/mL Antimycin A?

-0.409

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.662

PA_110-50 ug/mL Antitubercular compound PA-1?

1.109

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.205

PA8240.2-2 ug/mL PA-824?

-0.338

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.105

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.336

Verapamil50 uM Verapamil?

-0.222

mercaptoethanol2 mM 2-Mercaptoethanol?

0.253

methoxatin10-20 ug/mL Methoxatin?